NCT02432963 Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02365662 A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor Status TERMINATED Phase PHASE1
NCT02345330 Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC) Status TERMINATED Phase PHASE2
NCT02318771 Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer Status COMPLETED Phase PHASE1
NCT02279459 Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas Status COMPLETED Phase N/A
NCT02270814 Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02268695 Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC Status COMPLETED Phase PHASE2
NCT02255097 Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055) Status COMPLETED Phase PHASE2
NCT02207439 Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT02143622 Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients Status WITHDRAWN Phase PHASE1/PHASE2
NCT02126189 The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study Status UNKNOWN Phase N/A
NCT02047201 Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC Status COMPLETED Phase PHASE2
NCT02004639 Trismus Prevention, Diagnosis and Management: Radiotherapy Planning, Early Detection, and Physical Therapy Intervention Status UNKNOWN Phase NA
NCT02003482 Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer Status COMPLETED Phase N/A
NCT01975688 A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis Status TERMINATED Phase PHASE1
NCT01950689 NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab) Status COMPLETED Phase PHASE3
NCT01864850 Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC Status COMPLETED Phase PHASE3
NCT01852292 Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy Status TERMINATED Phase PHASE2